Alcohol and the Social Brain: an Alcohol-Administration Hyperscanning Study
Launched by UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · Nov 11, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how alcohol affects the brain, especially in social situations. The researchers want to understand how drinking alcohol can influence the way we interact with others and what happens in our brains when we consume alcohol in a social setting. They are looking for participants who are between 21 and 30 years old and regularly drink alcohol.
If you join the study, you will be part of a group of people who will undergo some tests while consuming a controlled amount of alcohol. It's important to note that you cannot participate if you have had serious problems with alcohol in the past, are on certain medications, or have specific medical conditions. Additionally, if you are pregnant or trying to become pregnant, you won't be eligible. The study is currently recruiting participants, and everyone, regardless of gender, is welcome to apply.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Between the ages of 21 and 30
- • Regularly consumes alcohol
- Exclusion Criteria:
- • History of adverse reaction to the amount of beverage employed in the study
- • Have a history of major problems associated with alcohol
- • Take medications that could adversely interact with alcohol
- • Have medical conditions that contraindicate alcohol administration
- • Individuals with a history of skull fractures or who indicate discomfort with EEG procedures used
- • Female participant is pregnant or trying to become pregnant
About University Of Illinois At Urbana Champaign
The University of Illinois at Urbana-Champaign is a leading research institution dedicated to advancing knowledge and innovation in various fields, including health sciences. With a strong commitment to rigorous scientific inquiry, the university conducts clinical trials aimed at improving patient outcomes and understanding complex health challenges. Leveraging its multidisciplinary expertise and state-of-the-art facilities, the university collaborates with healthcare professionals and researchers to explore novel therapeutic interventions and enhance evidence-based practices. Through its clinical trials, the University of Illinois at Urbana-Champaign strives to contribute significantly to the advancement of medical science and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Champaign, Illinois, United States
Patients applied
Trial Officials
Catharine E Fairbairn, Ph.D.
Principal Investigator
University of Illinois at Urbana-Champaign
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported